Immunostep

About:

Immunostep is a biotechnology company that develops flow chemistry products for diagnostic and research applications.

Website: http://www.immunostep.com/

Twitter/X: Immunostep

Top Investors: Alentia

Description:

Immunostep is a biotechnology company that develops flow chemistry products for diagnostic and research applications. The company’s products include antibodies and their conjugates, human recombinant proteins, vials, staining solutions, and stability reagents. It also offers mono and polyclonal development, peptide production, antibodies conjugation, monoclonal antibodies and polyclonal sera purification, hybridomas or cell lines storing, technical assistance in antibody production, specific antigenic peptides identification, homology search, and secondary and tertiary structure analysis services. Immunostep offers its products through distributors in Brazil, Peru, the United Kingdom, Germany, Poland, Italy, Spain, India, and Korea. It was founded in January 2000 and is based in Salamanca, Spain.

Total Funding Amount:

1.2M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Salamanca, Castilla y Leon, Spain

Founded Date:

2000-01-01

Contact Email:

info(AT)immunostep.com

Founders:

Alfredo Conde, Ricardo Jara

Number of Employees:

11-50

Last Funding Date:

2016-05-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai